Katri Kaukinen

Summary

Affiliation: University of Tampere
Country: Finland

Publications

  1. ncbi [Should celiac disease be screened on the population level?]
    Katri Kaukinen
    TAYS gastroenterologian vastuualue ja Tampereen yliopiston lääketieteen laitos, Tampereen yliopisto
    Duodecim 121:1361-2. 2005
  2. ncbi Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study
    Pilvi Paarlahti
    Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland
    BMC Gastroenterol 13:75. 2013
  3. ncbi Spectrum of gluten-related disorders: consensus on new nomenclature and classification
    Anna Sapone
    Mucosal Biology Research Center and Center for Celiac Research, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    BMC Med 10:13. 2012
  4. ncbi Clinical benefit of gluten-free diet in screen-detected older celiac disease patients
    Anitta Vilppula
    Department of Neurology, Paijat Hame Central Hospital, Lahti, Finland
    BMC Gastroenterol 11:136. 2011
  5. ncbi IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease
    Elisabet Einarsdottir
    Department of Medical Genetics, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
    BMC Med Genet 10:8. 2009
  6. ncbi Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits
    T T Salmi
    Medical School, University of Tampere, Finland 33014
    Gut 55:1746-53. 2006
  7. ncbi Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit
    Katri Kaukinen
    Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Finland
    Scand J Gastroenterol 42:1428-33. 2007
  8. ncbi Coeliac disease--a diagnostic and therapeutic challenge
    Katri Kaukinen
    Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland
    Clin Chem Lab Med 48:1205-16. 2010
  9. ncbi Antibodies against deamidated gliadin peptides in early-stage celiac disease
    Kalle Kurppa
    Pediatric Research Centre, University of Tampere, Helsinki, Finland
    J Clin Gastroenterol 45:673-8. 2011
  10. ncbi Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study
    Kalle Kurppa
    Paediatric Research Centre, University of Tampere and Tampere University Hospital, Tampere, Finland
    Gastroenterology 136:816-23. 2009

Detail Information

Publications86

  1. ncbi [Should celiac disease be screened on the population level?]
    Katri Kaukinen
    TAYS gastroenterologian vastuualue ja Tampereen yliopiston lääketieteen laitos, Tampereen yliopisto
    Duodecim 121:1361-2. 2005
  2. ncbi Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study
    Pilvi Paarlahti
    Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland
    BMC Gastroenterol 13:75. 2013
    ..We aimed to find predictors for these continuous health concerns in long-term treated adult coeliac patients...
  3. ncbi Spectrum of gluten-related disorders: consensus on new nomenclature and classification
    Anna Sapone
    Mucosal Biology Research Center and Center for Celiac Research, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    BMC Med 10:13. 2012
    ....
  4. ncbi Clinical benefit of gluten-free diet in screen-detected older celiac disease patients
    Anitta Vilppula
    Department of Neurology, Paijat Hame Central Hospital, Lahti, Finland
    BMC Gastroenterol 11:136. 2011
    ..It remains obscure whether screening makes good or harm in subjects with long-standing gluten ingestion. We evaluated whether older subjects benefit from active detection and subsequent gluten free dietary treatment of celiac disease...
  5. ncbi IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease
    Elisabet Einarsdottir
    Department of Medical Genetics, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
    BMC Med Genet 10:8. 2009
    ..IL23R also associates with psoriasis, suggesting that the gene may be an important candidate for many chronic inflammatory diseases...
  6. ncbi Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits
    T T Salmi
    Medical School, University of Tampere, Finland 33014
    Gut 55:1746-53. 2006
    ..Some patients with untreated coeliac disease are negative for serum endomysial autoantibodies (EmA) targeted against transglutaminase 2 (TG2)...
  7. ncbi Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit
    Katri Kaukinen
    Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Finland
    Scand J Gastroenterol 42:1428-33. 2007
    ..The purpose of this study was to compare these serological tests with a new test recognizing antibodies against deamidated and defined gliadin peptides...
  8. ncbi Coeliac disease--a diagnostic and therapeutic challenge
    Katri Kaukinen
    Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland
    Clin Chem Lab Med 48:1205-16. 2010
    ..Currently, the only effective treatment for the condition is a life-long strict gluten-free diet. Long-term regular follow-up of patients is recommended in order to maintain good adherence to the diet...
  9. ncbi Antibodies against deamidated gliadin peptides in early-stage celiac disease
    Kalle Kurppa
    Pediatric Research Centre, University of Tampere, Helsinki, Finland
    J Clin Gastroenterol 45:673-8. 2011
    ..We hypothesized that the antibodies against deamidated gliadin peptides (DGP-AGA) might appear before the other antibodies and would thus be useful in the diagnosis and follow-up of patients with early-stage celiac disease...
  10. ncbi Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study
    Kalle Kurppa
    Paediatric Research Centre, University of Tampere and Tampere University Hospital, Tampere, Finland
    Gastroenterology 136:816-23. 2009
    ..We hypothesized that patients with mild enteropathy but positive endomysial antibodies benefit from a gluten-free diet (GFD) similarly to patients with more severe enteropathy...
  11. ncbi Serological responses to microbial antigens in celiac disease patients during a gluten-free diet
    Sara Ashorn
    Paediatric Research Centre and Medical School, University of Tampere and Tampere University Hospital, Tampere, Finland
    J Clin Immunol 29:190-5. 2009
    ..Further, we wanted to evaluate whether these serologic specificities could provide new tools for the follow-up of CD patients...
  12. ncbi Serodiagnostic assays for celiac disease based on the open or closed conformation of the autoantigen, transglutaminase 2
    Katri Lindfors
    Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere, Finland
    J Clin Immunol 31:436-42. 2011
    ..It thus offers a promising tool in the diagnostics and follow-up of celiac disease...
  13. ncbi Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups
    Kalle Kurppa
    University of Tampere, Tampere, Finland
    J Pediatr Gastroenterol Nutr 54:387-91. 2012
    ..The utility of these new criteria was evaluated by applying the human red blood cell TG2 antibody test (RBC-TG2ab) to a large cohort of children and adults belonging to at-risk groups...
  14. ncbi Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease
    Marja Leena Lähdeaho
    Paediatric Research Centre and School of Medicine, University of Tampere and Tampere University Hospital, Tampere, Finland
    BMC Gastroenterol 11:129. 2011
    ..We challenged adult celiac patients with gluten with a view to assessing the amount needed to cause some small-bowel mucosal deterioration...
  15. ncbi Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease
    Outi Koskinen
    Pediatric Research Centre, University of Tampere, Finland
    J Pediatr Gastroenterol Nutr 47:436-42. 2008
    ..We evaluated the gluten dependency of these deposits in overt and mild enteropathy coeliac disease...
  16. ncbi Burden of illness in screen-detected children with celiac disease and their families
    Sampsa Kinos
    School of Medicine, University of Tampere, Tampere, Finland
    J Pediatr Gastroenterol Nutr 55:412-6. 2012
    ..We assessed health and well-being and the effect of a 1-year gluten-free diet in a nationwide cohort of children with celiac disease detected by screening in at-risk groups...
  17. ncbi Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation
    Kalle Kurppa
    Pediatric Research Centre, University of Tampere and Tampere University Hospital, FIN 33014, Tampere, Finland
    World J Gastroenterol 18:2511-6. 2012
    ..To investigate the association between serum antibody levels and a subsequent celiac disease diagnosis in a large series of children and adults...
  18. ncbi Intestinal transglutaminase 2 specific antibody deposits in non-responsive coeliac disease
    Outi Koskinen
    Pediatric Research Center and Medical School, University of Tampere, FIN 33014 Tampere, Finland
    Dig Liver Dis 42:692-7. 2010
    ..We investigated whether small-bowel mucosal transglutaminase-2 specific autoantibody deposits distinguish non-responsive coeliac disease from other enteropathies...
  19. ncbi Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits
    Satumarja M Stenman
    Medical School, Pediatric Research Center, University of Tampere, Tampere, Finland
    BMC Immunol 9:6. 2008
    ....
  20. ncbi IgA-class autoantibodies against neuronal transglutaminase, TG6 in celiac disease: no evidence for gluten dependency
    Katri Lindfors
    Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere, Finland
    Clin Chim Acta 412:1187-90. 2011
    ..We here investigated whether TG6-targeted autoantibodies are a characteristic feature of celiac patients, especially those with neurological symptoms, and further, whether such antibodies are gluten-dependent...
  21. ncbi Lower economic status and inferior hygienic environment may protect against celiac disease
    Anita Kondrashova
    Department of Virology, University of Tampere, Medical School, Tampere, Finland
    Ann Med 40:223-31. 2008
    ..The populations in adjacent Russian Karelia and Finland are equally exposed to grain products and share partly the same ancestry, but live in completely different socioeconomic environments...
  22. ncbi Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease
    Outi Koskinen
    Pediatric Research Center, University of Tampere, Tampere, Finland
    J Clin Gastroenterol 44:483-8. 2010
    ..Furthermore, as the often compromised quality of biopsy specimens renders diagnosis difficult, new diagnostic tools are warranted...
  23. ncbi Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies
    Sergio Caja
    Paediatric Research Centre, Medical School, University of Tampere, Tampere, Finland
    Scand J Gastroenterol 45:421-7. 2010
    ..In addition, we studied whether the monoclonal patient autoantibodies modulate endothelial cell TG2 activity and whether such modulation is related to the anti-angiogenic effects...
  24. ncbi Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Katri Lindfors
    Paediatric Research Center, University of Tampere and Tampere University Hospital, Tampere, Finland
    Autoimmun Rev 9:744-9. 2010
    ..In this review we discuss the role of TG2, the autoantigen and the autoantibodies targeted against it in the pathogenesis of celiac disease...
  25. ncbi Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study
    Tiina Rauhavirta
    Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere, 33014, Finland
    J Clin Immunol 33:134-42. 2013
    ..In this proof-of-concept study we investigated whether two TG2 inhibitors, cell-impermeable R281 and cell-permeable R283, can prevent the toxic effects of gliadin in vitro and ex vivo...
  26. ncbi Celiac disease: from inflammation to atrophy: a long-term follow-up study
    Marja Leena Lähdeaho
    Department of Pediatrics and Internal Medicine, Tampere University Hospital and Medical School, University of Tampere, Finland
    J Pediatr Gastroenterol Nutr 41:44-8. 2005
    ..The aim of this study was to evaluate the role of intraepithelial lymphocytosis and marginally decreased villous height/crypt depth ratio in the development of overt villous atrophy in a long-term follow-up...
  27. ncbi Use of health care services and pharmaceutical agents in coeliac disease: a prospective nationwide study
    Anniina Ukkola
    School of Medicine, FinnMedi3, University of Tampere, FIN 33014, Tampere, Finland
    BMC Gastroenterol 12:136. 2012
    ..Unexplained symptoms may lead to incremented medical consultations and productivity losses. The aim here was to estimate the possible concealed burden of untreated coeliac disease and the effects of a gluten-free diet...
  28. ncbi Symptom-detected and screen-detected celiac disease and adult height: a large cohort study
    Aleksi Pärnänen
    Pediatric Research Centre, Tampere University Hospital, Tampere, Finland
    Eur J Gastroenterol Hepatol 24:1066-70. 2012
    ..We aimed to assess the final height in a large cohort of symptom-detected and screen-detected patients with celiac disease diagnosed in adulthood...
  29. ncbi RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies
    Stefania Martucciello
    Pediatric Research Center, University of Tampere, Tampere University Hospital, Finn Medi 3, School of Medicine 33014, University of Tampere, Finland
    J Mol Med (Berl) 90:817-26. 2012
    ..Taken together, our results would suggest that RhoB plays a key role in the response of endothelial cells to celiac disease-specific anti-TG2 autoantibodies...
  30. ncbi Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA
    Essi Myrsky
    Pediatric Research Center, Medical School, University of Tampere, Tampere, Finland
    Cell Mol Life Sci 66:3375-85. 2009
    ....
  31. ncbi Altered small-bowel mucosal vascular network in untreated coeliac disease
    Essi Myrsky
    Paediatric Research Centre, Medical School, University of Tampere
    Scand J Gastroenterol 44:162-7. 2009
    ..The purpose of this study was to establish whether the small-bowel mucosal vasculature is altered in coeliac disease and whether the putative changes are gluten dependent...
  32. ncbi IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease
    Katri Kaukinen
    Department of Internal Medicine, University of Tampere, Tampere, Finland
    Eur J Gastroenterol Hepatol 14:311-5. 2002
    ..Small bowel biopsy is therefore still necessary to ensure that the gluten-free diet is adequate...
  33. ncbi Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease
    Outi Koskinen
    Paediatric Research Centre, University of Tampere, Tampere, Finland
    J Pediatr Gastroenterol Nutr 48:559-65. 2009
    ....
  34. ncbi Coeliac disease, autoimmune diseases and gluten exposure
    Mervi Viljamaa
    Department of Internal Medicine, Tampere University Hospital, Finland
    Scand J Gastroenterol 40:437-43. 2005
    ..CONCLUSIONS: Despite that fact that patients with coeliac disease are at increased risk of various autoimmune conditions, the duration of gluten exposure seems not to be of crucial importance in the development of autoimmune diseases...
  35. ncbi In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options
    Katri Lindfors
    Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere, Finland
    Exp Biol Med (Maywood) 237:119-25. 2012
    ....
  36. ncbi Galactosylation of serum IgA1 O-glycans in celiac disease
    Katri Lindfors
    Pediatric Research Center, University of Tampere and Tampere University Hospital, Finn Medi 3, FIN 33014 Tampere, Finland
    J Clin Immunol 31:74-9. 2011
    ..Thus, the undergalactosylated IgA1 molecules are not pathognomonic for celiac disease, but galactose deficiency in IgA1 could be an aggravating factor...
  37. ncbi An update on the diagnostics of celiac disease
    Katri Lindfors
    Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere, Finland
    Int Rev Immunol 30:185-96. 2011
    ..Furthermore, the diagnostic criteria for celiac disease are currently under revision with an eye also to noninvasive diagnostic strategies...
  38. ncbi Gluten-sensitive hypertransaminasemia in celiac disease: an infrequent and often subclinical finding
    Satu Korpimäki
    Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere, Finland
    Am J Gastroenterol 106:1689-96. 2011
    ..We investigated the prevalence and gluten dependency of hypertransaminasemia in celiac patients also diagnosed with minor or atypical symptoms...
  39. ncbi Gastrointestinal symptoms, quality of life and bone mineral density in mild enteropathic coeliac disease: a prospective clinical trial
    Kalle Kurppa
    Paediatric Research Centre, University of Tampere and Tampere University Hospital, Tampere, Finland
    Scand J Gastroenterol 45:305-14. 2010
    ..The aim of this study was to evaluate gastrointestinal symptoms, quality of life and bone mineral density in patients with mild enteropathy, and the effect of a gluten-free diet...
  40. ncbi Comparison of a novel whole blood transglutaminase-based ELISA with a whole blood rapid antibody test and established conventional serological celiac disease assays
    Tiina Raivio
    Paediatric Research Centre, University of Tampere, Finland
    J Pediatr Gastroenterol Nutr 47:562-7. 2008
    ..We assessed the value of this new test in celiac disease antibody detection...
  41. ncbi Diet improves perception of health and well-being in symptomatic, but not asymptomatic, patients with celiac disease
    Anniina Ukkola
    Medical School, University of Tampere, Tampere, Finland
    Clin Gastroenterol Hepatol 9:118-23. 2011
    ..We investigated the impact of a gluten-free diet on self-perceived health and well-being in symptomatic and asymptomatic patients with celiac disease...
  42. ncbi Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease
    Juha Taavela
    Pediatric Research Centre, University of Tampere and Tampere University Hospital, Tampere, Finland
    Clin Gastroenterol Hepatol 11:166-71.e1. 2013
    ..We investigated whether the degree of mucosal damage to the small bowel correlates with clinical presentation and serum markers of celiac disease...
  43. ncbi Future treatment strategies for celiac disease
    Katri Lindfors
    University of Tampere and Tampere University Hospital, School of Medicine, Pediatric Research Center, Finn Medi 3, FIN 33014, Tampere, Finland
    Expert Opin Ther Targets 16:665-75. 2012
    ..It is thus likely that the first medication entering the market will be supplementary to rather than substitute the gluten-free diet...
  44. ncbi Latent coeliac disease or coeliac disease beyond villous atrophy?
    Katri Kaukinen
    Medical School, University of Tampere, Finland
    Gut 56:1339-40. 2007
  45. ncbi Should we screen reflux oesophagitis patients for coeliac disease?
    Pekka Collin
    Department of Medicine, Tampere University Hospital, University of Tampere, Finland
    Eur J Gastroenterol Hepatol 16:917-20. 2004
    ..Oesophagitis and gastro-oesophageal reflux have been implicated recently in the manifestations of coeliac disease. The aim was to investigate this association in a primary-care setting...
  46. ncbi Patients' experiences and perceptions of living with coeliac disease - implications for optimizing care
    Anniina Ukkola
    School of Medicine, University of Tampere and Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Finland
    J Gastrointestin Liver Dis 21:17-22. 2012
    ..Little is known regarding the impact of coeliac disease on daily living from patients' own viewpoints. The aim of the study was to investigate patients' perceptions of their disease, dietary treatment and self-rated healthcare needs...
  47. ncbi Changes in body mass index on a gluten-free diet in coeliac disease: a nationwide study
    Anniina Ukkola
    School of Medicine, University of Tampere, Tampere, Finland
    Eur J Intern Med 23:384-8. 2012
    ..The aim of the study was to evaluate the impact of a GFD on the body mass index (BMI) in a nationwide cohort of coeliac patients and to determine variables predictive of favourable or unfavourable BMI changes...
  48. ncbi Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study
    Anitta Vilppula
    Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland
    BMC Gastroenterol 9:49. 2009
    ....
  49. ncbi Celiac disease and health-related quality of life
    Kalle Kurppa
    Paediatric Research Center, University of Tampere and Tampere University Hospital, FIN 33014, Finland
    Expert Rev Gastroenterol Hepatol 5:83-90. 2011
    ..This article highlights the studies of health-related quality of life and celiac disease conducted to date. Particular attention is paid to the extraintestinal and atypical forms of the disorder...
  50. ncbi Inhibition of epithelial growth factor receptor signalling does not preserve epithelial barrier function after in vitro gliadin insult
    Kati Juuti-Uusitalo
    Paediatric Research Centre, Medical School, University of Tampere, Finland
    Scand J Gastroenterol 44:820-5. 2009
    ....
  51. ncbi Celiac disease without villous atrophy in children: a prospective study
    Kalle Kurppa
    Pediatric Research Centre, University of Tampere and Tampere University Hospital, Tampere, Finland
    J Pediatr 157:373-80, 380.e1. 2010
    ..To establish whether children who are endomysial antibody (EmA) positive and have normal small-bowel mucosal villous morphology are truly gluten-sensitive and may benefit from early treatment with a gluten-free diet...
  52. ncbi HLA-DQ typing in the diagnosis of celiac disease
    Katri Kaukinen
    Department of Internal Medicine, Tampere University Hospital, Finland
    Am J Gastroenterol 97:695-9. 2002
    ..CONCLUSIONS: HLA-DQ2 and -DQ8 determination is useful in exclusion, probably lifelong, of celiac disease in individuals with an equivocal small bowel histological finding. The low specificity of this test must, however, be borne in mind...
  53. ncbi Factors associated with dietary adherence in celiac disease: a nationwide study
    Kalle Kurppa
    Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere, Finland
    Digestion 86:309-14. 2012
    ..In a country with a high prevalence and good general knowledge of celiac disease, only age at diagnosis and age at present would appear to be major determinants for adherence...
  54. ncbi Gastrointestinal symptoms and quality of life in screen-detected celiac disease
    Aku Paavola
    School of Medicine, University of Tampere, Tampere, Finland
    Dig Liver Dis 44:814-8. 2012
    ..The effects of a long-term gluten-free diet on possible gastrointestinal symptoms and psychological well-being in screen-detected patients have nevertheless remained obscure...
  55. ncbi Video capsule endoscopy in celiac disease: current clinical practice
    Pekka Collin
    Department of Gastroenterology and Alimentary Tract Surgery, Medical School, University of Tampere, Tampere, Finland
    J Dig Dis 13:94-9. 2012
    ..A complete examination of the small intestine is possible by video capsule endoscopy (VCE). The aim of this study was to evaluate current indications for performing VCE in celiac disease...
  56. ncbi Antibodies in celiac disease: implications beyond diagnostics
    Sergio Caja
    Pediatric Research Centre, University of Tampere and Tampere University Hospital, Tampere, Finland
    Cell Mol Immunol 8:103-9. 2011
    ..The article summarizes the diagnostic utility of different celiac-related antibodies and discusses their roles in the pathogenesis of the disease...
  57. ncbi Serum fatty acid profile in subjects with irritable bowel syndrome
    Tiina Solakivi
    Department of Medical Biochemistry, University of Tampere, Finland
    Scand J Gastroenterol 46:299-303. 2011
    ..We wanted to investigate subjects with IBS for signs of disturbed intestinal absorption of fatty acids, as reflected in serum composition...
  58. ncbi Age, symptoms and upper gastrointestinal malignancy in primary care endoscopy
    Maarit Salo
    Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland
    Scand J Gastroenterol 43:122-7. 2008
    ..Upper gastrointestinal complaints are common in the general population. The aim of this study was to establish whether age and occurrence of alarm symptoms are predictors of malignancy in primary care open-access endoscopy...
  59. ncbi Intraepithelial lymphocytes in celiac disease
    Teea T Järvinen
    Department of Internal Medicine, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland
    Am J Gastroenterol 98:1332-7. 2003
    ..The aim of this study was to investigate the value of immunohistochemical characterization of different intraepithelial lymphocytes (IELs) in the diagnostic workup of celiac disease (CD)...
  60. ncbi Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease
    Satumarja M Stenman
    Pediatric Research Center, Medical School, University of Tampere, Finland
    Ann Med 41:390-400. 2009
    ..We isolated proteases from germinating wheat grain naturally meant for total digestion of wheat storage proteins and investigated whether these enzymes can diminish toxic effects of gluten in vitro and ex vivo...
  61. ncbi Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study
    Sini Lohi
    Paediatric Research Center, Medical School, University of Tampere, Tampere, Finland
    Ann Med 41:508-15. 2009
    ..Clinically diagnosed coeliac disease patients carry an increased risk of mortality. As coeliac disease is markedly underdiagnosed, we aimed to quantify the risk of mortality in subjects with unrecognized and thus untreated coeliac disease...
  62. ncbi The prevalence of celiac disease in Europe: results of a centralized, international mass screening project
    Kirsi Mustalahti
    Paediatric Research Centre, University of Tampere and Department of Paediatrics, Tampere University Hospital, Tampere, Finland
    Ann Med 42:587-95. 2010
    ....
  63. ncbi The diagnostic value of video capsule endoscopy
    Heidi Niemenmaa
    Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery and University of Tampere, Tampere, Finland
    Eur J Intern Med 21:383-5. 2010
    ..Video capsule endoscopy (VCE) offers the best means of studying small bowel, but is expensive. We investigated how physicians appraise the value of VCE...
  64. ncbi Recent advances in the development of new treatments for celiac disease
    Marja Leena Lähdeaho
    University of Tampere, Tampere University Hospital, Pediatric Research Centre, Tampere, Finland
    Expert Opin Biol Ther 12:1589-600. 2012
    ..Furthermore, the gluten dose that can be detoxified, if at all, must be established. The new drug should also be as safe as dietary treatment. Several novel treatment options are under development...
  65. ncbi Oats can diversify a gluten-free diet in celiac disease and dermatitis herpetiformis
    Markku Peräaho
    Department of Medicine, Tampere University Hospital, Tampere, Finland
    J Am Diet Assoc 104:1148-50. 2004
    ..There is a market demand for oats, and celiac societies and dietitians should make efforts to promote the development of products free of wheat contamination...
  66. ncbi Chronic gastritis in dermatitis herpetiformis: a controlled study
    Anna Alakoski
    Department of Dermatology, Tampere University Hospital, 33521 Tampere, Finland
    Clin Dev Immunol 2012:640630. 2012
    ..Previous small studies suggest that chronic atrophic gastritis is common in dermatitis herpetiformis (DH). We here examined the frequency and topography of chronic gastritis in 93 untreated DH subjects and in 186 controls with dyspepsia...
  67. ncbi Gluten-free diet and autoimmune thyroiditis in patients with celiac disease. A prospective controlled study
    Saara Metso
    Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
    Scand J Gastroenterol 47:43-8. 2012
    ..We investigated the course of autoimmune thyroid diseases in newly diagnosed celiac disease patients before and after gluten-free dietary treatment...
  68. ncbi Type 1 diabetes is associated with enterovirus infection in gut mucosa
    Maarit Oikarinen
    Department of Virology, School of Medicine, University of Tampere, Tampere, Finland
    Diabetes 61:687-91. 2012
    ..This finding opens new opportunities for studying the viral etiology of type 1 diabetes...
  69. ncbi Serum fatty acid profile in celiac disease patients before and after a gluten-free diet
    Tiina Solakivi
    Department of Medical Biochemistry, University of Tampere, Finland
    Scand J Gastroenterol 44:826-30. 2009
    ..In untreated CD, fat malabsorption can occur. The aim of this study was to investigate the profile of serum fatty acids in newly detected CD before and after treatment with a gluten-free diet...
  70. ncbi Endocrinological disorders and celiac disease
    Pekka Collin
    Department of Medicine, Tampere University Hospital and University of Tampere, 33014 Tampere, Finland
    Endocr Rev 23:464-83. 2002
    ..Celiac disease will be increasingly detected provided the close association with autoimmune endocrinological diseases is recognized...
  71. ncbi Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study
    Pekka Collin
    Tampere University Hospital and University of Tampere, Finland
    Eur J Gastroenterol Hepatol 17:85-91. 2005
    ..The setting allowed a further comparison between the antibody results and the conventional small-intestinal histology...
  72. ncbi Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease
    Sara Ashorn
    Paediatric Research Centre and Medical School, University of Tampere and Tampere University Hospital, Tampere, Finland
    J Clin Immunol 28:486-94. 2008
    ....
  73. ncbi Psychoneurotic symptoms and alexithymia in coeliac disease
    Pekka Collin
    Department of Gastroenterology and Alimentary Tract Surgery, Medical School, Tampere University Hospital, Tampere, Finland
    Scand J Gastroenterol 43:1329-33. 2008
    ..The aim of this study was to evaluate whether patients with coeliac disease suffer from psychoneurotic symptoms or alexithymia, and whether a gluten-free diet has an impact on the symptoms...
  74. ncbi Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure
    Katri Kaukinen
    Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
    Gastroenterology 122:881-8. 2002
    ..CONCLUSIONS: The possible presence of celiac disease should be investigated in patients with severe liver disease. Dietary treatment may prevent progression to hepatic failure, even in cases in which liver transplantation is considered...
  75. ncbi Gene expression in TGFbeta-induced epithelial cell differentiation in a three-dimensional intestinal epithelial cell differentiation model
    Kati M Juuti-Uusitalo
    Paediatric Research Centre, Tampere University and Tampere University Hospital, Tampere, Finland
    BMC Genomics 7:279. 2006
    ....
  76. ncbi Contribution of celiac disease autoantibodies to the disease process
    Katri Lindfors
    Pediatric Research Center, University of Tampere and Tampere University Hospital, 33014 Tampere, Finland
    Expert Rev Clin Immunol 8:151-4. 2012
    ..These findings provide an important direction for future research to improve our general understanding of celiac disease pathogenesis and especially the role of the disease-specific autoantibodies during the progression of the disorder...
  77. ncbi Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study
    Katri Kaukinen
    Department of Tissue Typing, Finnish Red Cross Blood Service, Helsinki, Finland
    Scand J Gastroenterol 40:564-72. 2005
    ..Mucosal transglutaminase 2-specific IgA deposits can be utilized in detecting such patients with genetic gluten intolerance...
  78. ncbi Immunohistochemical features in antiendomysium positive patients with normal villous architecture
    Katri Kaukinen
    Am J Gastroenterol 101:675-6. 2006
  79. ncbi Complete small intestine mucosal recovery is obtainable in the treatment of celiac disease
    Pekka Collin
    Gastrointest Endosc 59:158-9; author reply 159-60. 2004
  80. ncbi Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells
    Shyam Prasad
    Division of Infection, Inflammation and Repair, Southampton General Hospital, University of Southampton School of Medicine, Southampton, UK
    Lab Invest 85:1139-62. 2005
    ..These results suggest that INFgamma/TNFalpha and IL-13 have differential effects on CL 2, 3 and 4 in tight junctions, which may lead to increased permeability via different mechanisms...
  81. ncbi Celiac disease and HLA DQ in patients with IgA nephropathy
    Pekka Collin
    Am J Gastroenterol 97:2572-6. 2002
    ..It can be hypothesized that the increased intestinal permeability in IgA nephropathy may predispose genetically susceptible patients to celiac disease...
  82. ncbi Deficient activity of mammalian prolyl oligopeptidase on the immunoactive peptide digestion in coeliac disease
    J Arturo Garcia-Horsman
    Centro de Investigacion Principe Felipe, Valencia, Spain
    Scand J Gastroenterol 42:562-71. 2007
    ....
  83. ncbi Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study
    Ilma R Korponay Szabo
    Department of Paediatrics, Medical and Health Science Centre, University of Debrecen, 4032 Debrecen, Hungary
    BMJ 335:1244-7. 2007
    ..To evaluate the feasibility and diagnostic accuracy of screening for coeliac disease by rapid detection of IgA antibodies to tissue transglutaminase performed in primary care...
  84. ncbi Safe gluten threshold for patients with celiac disease: some patients are more tolerant than others
    Pekka Collin
    Am J Clin Nutr 86:260; author reply 260-1. 2007
  85. ncbi It is the compliance, not milligrams of gluten, that is essential in the treatment of celiac disease
    Pekka Collin
    Nutr Rev 62:490; author reply 491. 2004
  86. ncbi The diagnostic criteria of coeliac disease
    Pekka Collin
    Acta Paediatr 96:604. 2007